title: Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes.
authors.forename: Shoichiro
authors.initials: S
authors.lastname: Nagasaka
authors.forename: Ataru
authors.initials: A
authors.lastname: Taniguchi
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Aiso
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Yatagai
authors.forename: Tomoatsu
authors.initials: T
authors.lastname: Nakamura
authors.forename: Yoshikatsu
authors.initials: Y
authors.lastname: Nakai
authors.forename: Mitsuo
authors.initials: M
authors.lastname: Fukushima
authors.forename: Akira
authors.initials: A
authors.lastname: Kuroe
authors.forename: Shun
authors.initials: S
authors.lastname: Ishibashi
mesh_terms: D052242:Adiponectin; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D052242:Adiponectin; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins; D013453:Sulfonylurea Compounds; C057619:glimepiride